Talk:Proxalutamide

This is the talk page for discussing improvements to the Proxalutamide article.
This is not a forum for general discussion of the article's subject.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Tip: Anchors are case-sensitive in most browsers.

This article links to one or more target anchors that no longer exist.

[[Prostate cancer#Castration-resistant|mCRPC]] The anchor (#Castration-resistant) has been deleted by other users before.

Please help fix the broken anchors. You can remove this template after fixing the problems. | Reporting errors

Approval in Paraguay seems to be fake news[edit]

AUGUST 18, 2023

Prostate cancer drug proxalutamide shows promise against COVID.

91.159.191.100 (talk) 17:26, 19 August 2023 (UTC)[reply]